Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
- beauty
Ceramide 5
CAS 100403-19-8
Also registered as 2 other CAS numbers
111122-59-9 · 288072-63-9
Concern score
Not assessed — no hazard data yet.
Ceramide 5 in plain language
Also known as Ceramide 5 (retired) · Ceramide as (ceramide 5) · 2-OH-C24 :0 Ceramide · Cer(d18:1/24:0(2OH)) · N-(2-hydroxytetracosanoyl)-4-sphingenine · N-2-cerabronoylsphingosine
Show all 11 names
N-2-hydroxylignoceroylsphingosine · N-2-hydroxytetracosanoyl ceramide · N-2-hydroxytetracosanoylsphingosine · TIC-006 · UNII-7848GX36YB
Used in cosmetics as a skin-conditioning agent and a hair conditioner. Ceramide 5 (Retired) is the N-acylated sphingolipid having the erythro structure.
- Skin conditioning
- Hair conditioning
- We haven't assessed a concern score for this ingredient yet. It is listed for cosmetic use in the EU.
What we know about this ingredient
FDA GSRS classifies this ingredient as ingredient substance chemical.
Regulation
No restrictions found. Ceramide 5 appears in these published regulatory listings.
EUCosIngActiveCeramide 5 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsatuarated and n has a value ranging from 10 to 16. Ceramide 5 is similar to Ceramide 4, however, the acylating hydroxy acids are generally longer in Ceramide 5 than in Ceramide 4. The INCI Name, Ceramide 5, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 5 will be retained in the retired monograph, and also published with the new name assignment, Ceramide AS.
- Ceramide 5 (Retired) is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula, where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsatuarated and n has a value ranging from 10 to 16. Ceramide 5 is similar to Ceramide 4, however, the acylating hydroxy acids are generally longer in Ceramide 5 than in Ceramide 4. The INCI Name, Ceramide 5, originally developed in 1997, was designated with a retired status in 2014. For an interim period of time, trade name assignments formerly published with the INCI Name Ceramide 5 will be retained in the retired monograph, and also published with the new name assignment, Ceramide AS.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Expert safety opinions
No expert opinion on file for Ceramide 5. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.
SCCS
EU Scientific Committee on Consumer Safety
No SCCS opinion on file.
CIR
Cosmetic Ingredient Review (US expert panel)
No CIR safety assessment on file.
Evidence & sources
No graded research studies for Ceramide 5 yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
No signal in this context